Narayana Hrudayalaya Ltd
NSE:NH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 148.1
1 416.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd
Note Receivable
Narayana Hrudayalaya Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Note Receivable
₹4.3B
|
CAGR 3-Years
88%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
|
Note Receivable
₹1.3B
|
CAGR 3-Years
90%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Note Receivable
₹3.6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Note Receivable
₹8.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Note Receivable
₹5.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Note Receivable
₹899.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Narayana Hrudayalaya Ltd
Glance View
Narayana Hrudayalaya Ltd. engages in the provision of medical and health care services. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-01-06. The firm operates a network of hospitals, diagnostic centers, clinical centers or test laboratories. The firm operates through Medical and Healthcare Services business segment. The firm offers medical, surgery, and diagnostics and support services. The company provides services in the areas of cardiology; orthopedics; cosmetic surgery; anesthesia; imaging and radiology; nutrition and dietetics; physiotherapy; renal transplant; thoracic surgery; pediatrics surgery; medical oncology; surgical gastroenterology; dermatology; hematology; rheumatology; neurology; psychiatry and psychology, and others. The firm operates a network of approximately 20 hospitals (multispecialty and super specialty healthcare facilities), four heart centers and 19 primary care facilities (including clinics and information centers), across India and a hospital at Cayman Islands with approximately 6,181 operational beds.
See Also
What is Narayana Hrudayalaya Ltd's Note Receivable?
Note Receivable
4.3B
INR
Based on the financial report for Sep 30, 2024, Narayana Hrudayalaya Ltd's Note Receivable amounts to 4.3B INR.
What is Narayana Hrudayalaya Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
28%
Over the last year, the Note Receivable growth was 359%. The average annual Note Receivable growth rates for Narayana Hrudayalaya Ltd have been 88% over the past three years , 28% over the past five years .
You don't have any saved screeners yet
